Cryo-Cell pushes further into Europe:
This article was originally published in Clinica
Executive Summary
Cryo-Cell International, a US autologous umbilical cord cell bank, can expect major growth in Europe, the company's European chief operating officer Kees Kleinbloesem told the group's AGM last week. The centrepiece of recent successes has been a deal to open an autologous cord blood bank in Milan jointly with the Vatican-owned San Raphaelo Hospital in Milan. The Vatican has previously stated it support for autologous and/or clinical use of stem cells from umbilical cord blood, while being opposed to foetal or embryonic stem cells. Cryo-Cell is headquartered in Clearwater, Florida.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.